News from aptuit llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

07 Jul, 2016, 11:57 BST Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing

Activities have commenced for 3 gene therapy programs in rare disease indications Aptuit LLC, a premier global drug discovery and development CRO,...


10 May, 2016, 08:00 BST Aptuit Announces Acquisition of Kuecept Ltd

Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services ...


22 Feb, 2016, 14:00 GMT Aptuit and Icagen Agree to Strategic Alliance

Alliance to Provide Drug Discovery Customers Access to Industry Leading Ion Channel and Transporter Technologies Aptuit LLC and Icagen, Inc. today...


07 Dec, 2015, 08:00 GMT Aptuit Announces 16M$ Investment in Capacity and Capability

Significant increase in headcount, new capabilities in discovery and incremental increase in capacity in CMC Aptuit LLC announced it has commenced a...


30 Nov, 2015, 08:00 GMT Aptuit CEO, Jonathan Goldman, Joins the Columbia University Healthcare Advisory Board

We are very pleased to announce that Jonathan Goldman, CEO of Aptuit, has accepted a nomination to join the Columbia University Healthcare Advisory...


13 Jul, 2015, 11:00 BST Aptuit Announces Expansion of Integrated CMC Offering (Drug Substance and Drug Product) to Phase 3 and Commercial Scale

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license Aptuit...


14 Apr, 2015, 17:37 BST Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services

Aptuit LLC, a premier global drug discovery and development CRO and Axxam SpA, a leading discovery company with expertise in target biology and a...


09 Jan, 2015, 12:40 GMT Aptuit to Divest Two Non-Core Sites; Facilitates Reinvestment and Accelerated Growth in Core Area of Integrated Solutions

Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has divested its aseptic clinical manufacturing site in Glasgow, UK to Albany Molecular...


21 Aug, 2014, 21:23 BST Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses

Aptuit LLC announces that Aptuit SSCI, located in West Lafayette, Indiana, has enhanced its capabilities in the areas of structure determination and...


15 Jul, 2014, 19:00 BST Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of...


11 Jun, 2014, 21:19 BST Aptuit LLC Targets Scandinavian Life Science Prospects at Stockholm Events

Aptuit LLC has made a significant outreach to life science companies in Scandinavia through two important events that were held in Stockholm, Sweden...


08 Jan, 2013, 18:06 GMT Aptuit and Aegerion Sign Commercial API Supply Agreement

Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that Aptuit and Aegerion Pharmaceuticals, Cambridge, Massachusetts,...


13 Nov, 2012, 14:55 GMT Aptuit and GSK Extend Strategic Partnership

Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for...